BASTA JAMES Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$387,243.35

Insider Activity of BASTA JAMES

According to the SEC Form 4 filings, BASTA JAMES, being in a position of

  1. EVP, General Counsel at Intellia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11608 shares for $112,444,
    over all time since 2023-01-04, has bought 0 shares, and sold 29582 shares for $499,687.

Biography of BASTA JAMES

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $112,4442100

Comparison of Insiders on Amount of Buys and Sells

2026-03-02SaleIntellia Therapeutics, Inc.
NTLA
EVP, General Counsel
1,211
0.001%
$13.78$16,688-16.84%
2026-01-05SaleIntellia Therapeutics, Inc.
NTLA
EVP, General Counsel
10,397
0.0098%
$9.21$95,756+36.93%
2025-03-04SaleIntellia Therapeutics, Inc.
NTLA
EVP, General Counsel
2,572
0.0024%
$8.99$23,122+13.08%
2025-01-03SaleIntellia Therapeutics, Inc.
NTLA
EVP, General Counsel
7,074
0.007%
$12.18$86,161-19.95%
2024-03-04SaleIntellia Therapeutics, Inc.
NTLA
EVP, General Counsel
2,297
0.0024%
$32.99$75,778-33.73%
2024-01-03SaleIntellia Therapeutics, Inc.
NTLA
EVP, General Counsel
3,805
0.0043%
$29.46$112,095-22.09%
2023-03-02SaleIntellia Therapeutics, Inc.
NTLA
EVP, General Counsel
1,088
0.0012%
$43.88$47,741-18.12%
2023-01-04SaleIntellia Therapeutics, Inc.
NTLA
EVP, General Counsel
1,138
0.0012%
$37.21$42,345-3.42%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.